223 related articles for article (PubMed ID: 11127370)
1. How safe are our safe donors?
Srikrishna A; Sitalakshmi S; Damodar P
Indian J Pathol Microbiol; 1999 Oct; 42(4):411-6. PubMed ID: 11127370
[TBL] [Abstract][Full Text] [Related]
2. Infectious markers in blood donors of East Delhi: prevalence and trends.
Singh B; Kataria SP; Gupta R
Indian J Pathol Microbiol; 2004 Oct; 47(4):477-9. PubMed ID: 16295370
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of serologic markers for transfusion transmitted infectious diseases for allogeneic blood donors in Puerto Rico.
Martínez-Díaz H; Frye-Maldonado AC; Climent-Perís C; Vélez-Rosario R
P R Health Sci J; 1997 Sep; 16(3):255-8. PubMed ID: 9431563
[TBL] [Abstract][Full Text] [Related]
4. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India.
Garg S; Mathur DR; Garg DK
Indian J Pathol Microbiol; 2001 Oct; 44(4):409-12. PubMed ID: 12035351
[TBL] [Abstract][Full Text] [Related]
5. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
Diro E; Alemu S; G/Yohannes A
Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of transfusion transmissible infections among blood donors in western part of Turkey: a six-year study.
Uzun B; Güngör S; Demirci M
Transfus Apher Sci; 2013 Dec; 49(3):511-5. PubMed ID: 23491864
[TBL] [Abstract][Full Text] [Related]
7. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
Panhotra BR; Al-Bahrani A; Ul-Hassan Z
Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304
[TBL] [Abstract][Full Text] [Related]
9. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital].
Aydin F; Cubukçu K; Yetişkul S; Yazici Y; Kaklikkaya N
Mikrobiyol Bul; 2002 Jan; 36(1):85-90. PubMed ID: 12476771
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of transfusion transmissible infections among blood donors at the blood bank of a Medical College of Kolkata.
Karmakar PR; Shrivastava P; Ray TG
Indian J Public Health; 2014; 58(1):61-4. PubMed ID: 24748361
[TBL] [Abstract][Full Text] [Related]
14. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala.
Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S
Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
El-Hazmi MM
Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
[TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B virus (HBV) infection in healthy blood donors.
Duseja A; Sharma S; Subramanian PG; Agnihotri SK; Chakraborti A; Chawla Y
Indian J Pathol Microbiol; 2003 Oct; 46(4):690-2. PubMed ID: 15025384
[TBL] [Abstract][Full Text] [Related]
17. Status of infectious disease markers among blood donors in a teaching hospital, Bhairahawa, western Nepal.
Chander A; Pahwa VK
J Commun Dis; 2003 Sep; 35(3):188-97. PubMed ID: 15796411
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
Pahuja S; Sharma M; Baitha B; Jain M
Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
[TBL] [Abstract][Full Text] [Related]
19. HIV, hepatitis B and C infection status of the blood donors in a blood bank of a tertiary health care centre of Orissa.
Panda M; Kar K
Indian J Public Health; 2008; 52(1):43-4. PubMed ID: 18700722
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
